Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
BMC Cancer|December 13, 2006
Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral latent membrane protein 1 and the immunomodulatory protein galectin 9Cécile Keryer-Bibens, Catherine Pioche-Durieu, Cécile Villemant, et al.
BMC Cancer|December 20, 2007
Biological characterization of two xenografts derived from human CUPs (carcinomas of unknown primary)Delphine Lequin, Karim Fizazi, Saloua Toujani, et al.
Oncotarget|March 28, 2018
Interferon beta induces apoptosis in nasopharyngeal carcinoma cells via the TRAIL-signaling pathwayAnna Makowska, Lora Wahab, Till Braunschweig, et al.
Protein Expression and Purification|May 31, 2019
Detection of IgG directed against a recombinant form of Epstein-Barr virus BALF0/1 protein in patients with nasopharyngeal carcinomaZhouwulin Shao, Chloé Borde, Christophe H Marchand, et al.
International Journal of Cancer|September 24, 2004
TRAF interactions with raft-like buoyant complexes, better than TRAF rates of degradation, differentiate signaling by CD40 and EBV latent membrane protein 1Hector Ardila-Osorio, Catherine Pioche-Durieu, Francine Puvion-Dutilleul, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
Imaging and modulating antisense microdistribution in solid human xenograft tumor modelsJoseph D Mocanu, Kenneth W Yip, Julia Skliarenko, et al.
Cancer Medicine|June 17, 2014
Expression of two parental imprinted miRNAs improves the risk stratification of neuroblastoma patientsCharles-Henry Gattolliat, Gwénaël Le Teuff, Valérie Combaret, et al.
Journal of Virology|October 18, 2005
In nasopharyngeal carcinoma cells, Epstein-Barr virus LMP1 interacts with galectin 9 in membrane raft elements resistant to simvastatinCatherine Pioche-Durieu, Cécile Keryer, Sylvie Souquère, et al.
Pageof 9